<?xml version="1.0" encoding="UTF-8"?>
<fig id="f02" position="float">
 <label>Figure 2</label>
 <caption>
  <p>Illustrative scheme of ADE during SARS-CoV-2 infection. Left panel: First infection and lack of preexisting antibodies allow viral particles to interact with ACE-2. Middle panel: Preexisting low-affinity antibodies or antibodies at sub-optimal concentrations bind to viral particles and facilitate the viral internalization mediated by FcRs expressed on either the epithelial or immune cells. Right panel: Neutralizing IgGs elicited in response to vaccination, or neutralizing IgM that do not mediate enhancement bind to viral particles. Illustration created by the authors using 
   <ext-link ext-link-type="uri" xlink:href="www.biorender.com" xmlns:xlink="http://www.w3.org/1999/xlink">www.biorender.com</ext-link>.
  </p>
 </caption>
 <graphic xlink:href="cln-75-e1912-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
